Skip to main content
Log in

Association between TNF promoter −308 G>A and LTA 252 A>G polymorphisms and systemic lupus erythematosus

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Tumor necrosis factor (TNF) and lymphotoxin alpha (LTA) are pivotal cytokines in the pathogenesis of systemic lupus erythematosus (SLE). To investigate the possible association of the polymorphism of the TNF promoter gene −308 and that of the LTA gene 252 with susceptibility to SLE and with phenotypic disease features in Egyptian patients. A case control study involving 100 SLE patients and 100 unrelated healthy controls. Polymerase chain reaction and restriction fragment length polymorphism methods were applied to detect genetic polymorphism. We found that TNF−308 genotype AA was significantly increase by 26 % in SLE patients compared to 10 % in the control group (p = 0.003; OR 3.16; CI 1.43–6.98) and the frequency of the A allele of the TNF promoter −308 was significantly higher in the SLE patients (42 %) than in the control subjects (24 %) (p < 0.001; OR 2.29; 95 % CI 1.49–3.52). Genotype LTA 252 GG showed a significant increase by 22 % in SLE patients compared to 6 % in the control group (p = 0.001; OR 4.42; 95 % CI 1.71–11.44), and the frequency of the G allele of the LTA was significantly higher in the SLE patients (38 %) than in the control subjects (21 %) (p < 0.001; OR 2.31; 95 % CI 1.48–3.6). Genotype (AA+GA) of TNF was significantly associated with clinical manifestations as malar rash, arthritis, oral ulcers, serositis and systemic lupus erythematosus disease activity index. Genotype (GG+GA) of LTA was significantly associated with arthritis. These results suggest that TNF and LTA genetic polymorphisms contribute to SLE susceptibility in the Egyptian population and are associated with disease characteristics. TNF−308 and LTA+252 polymorphic markers may be used for early diagnosis of SLE and early prediction of clinical manifestations, like arthritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sestak AL, Nath SK, Sawalha AH, Harley JB (2007) Current status of lupus genetics. Arthritis Res Ther 9:210

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Parham, Peter (2005) Chapter 6: T-cell mediated immunity. The immune system, 2nd edn. Garland Science, New York, p 172. ISBN 0-8153-4093-1

    Google Scholar 

  3. Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer Vischer T, Yazici H, Guerne PA (1997) Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. J Rheumatol 24:303–308

    CAS  PubMed  Google Scholar 

  4. Zhu L, Yang X, Ji Y, Chen W, Guan W, Zhou SF, Yu X (2009) Up-regulated renal expression of TNF-alpha signaling adapter proteins in lupus glomerulonephritis. Lupus 18:116–127

    Article  CAS  PubMed  Google Scholar 

  5. Matsumura R, Umemiya K, Sugiyama T, Sueishi M, Umibe T, Ichikawa K, Yoshimura M (2009) Anti-tumor necrosis factor therapy in patients with difficult-to-treat lupus nephritis: a prospective series of nine patients. Clin Exp Rheumatol 27:416–421

    CAS  PubMed  Google Scholar 

  6. Körner H, Sedgwick JD (1996) Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissue-specific autoimmunity. Immunol Cell Biol 74:465–472

    Article  PubMed  Google Scholar 

  7. Karimi M, Goldie LC, Cruickshank MN, Moses EK, Abraham LJ (2009) A critical assessment of the factors a vecting reporter gene assays for promoter SNP function: a reassessment of −308 TNF polymorphism function using a novel integrated reporter system. Eur J Hum Genet 17:1454–1462

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Lee YH, Harley JB, Nath SK (2006) Meta-analysis of TNF-alpha promoter −308 A/G polymorphism and SLE susceptibility. Eur J Hum Genet 14:364–371

    Article  CAS  PubMed  Google Scholar 

  9. Bettinotti MP, Hartung K, Deicher H, Messer G, Keller E, Weiss EH, Albert ED (1993) Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics 37:449–454

    Article  CAS  PubMed  Google Scholar 

  10. Zhang J, Ai R, Chow F (1997) The polymorphisms of HLA-DR and TNF B loci in northern Chinese Han nationality and susceptibility to systemic lupus erythematosus. Chin Med Sci J 12:107–110

    CAS  PubMed  Google Scholar 

  11. Parks CG, Pandey JP, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Feghali-Bostwick CA, Cooper GS (2004) Genetic polymorphisms in tumor necrosis factor (TNF)-alpha and TNF-beta in a population based study of systemic lupus erythematosus: associations and interaction with the interleukin-1 alpha-889 C/T polymorphism. Hum Immunol 65:622–631

    Article  CAS  PubMed  Google Scholar 

  12. Santos MJ, Carmona-Fernandes D, Caetano-Lopes J, Inês P, Vidal PB, Capela S, Canas da Silva J, Fonseca JE (2011) TNF promoter −308 G>A and LTA 252 A>G polymorphisms in Portuguese patients with systemic lupus erythematosus. Rheumatol Int 32(8):2239–2244

    Article  CAS  PubMed  Google Scholar 

  13. Hochberg MC (1997) Updating the American college of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725

    Article  CAS  PubMed  Google Scholar 

  14. Gladman DD, Ibañez D, Urowitz MB (2000) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288–291

    Google Scholar 

  15. Nath SK, Kilpatrick J, Harley JB (2004) Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol 16:794–800

    Article  CAS  PubMed  Google Scholar 

  16. Kim HY, Lee SH, Yang HI, Park SH, Cho CS, Kim TG et al (1995) TNFB gene polymorphism in patients with systemic lupus erythematosus in Korean. Korean J Intern Med 10:130–136

    CAS  PubMed  Google Scholar 

  17. Stienberg AD (1992) Systemic lupus erythematosus. In: Bennett JC (ed) Cecil textbook of medicine, 19th edn. Saunders, Philadelphia, p 1522

    Google Scholar 

  18. Ziakas PD, Routsias JG, Giannouli S, Tasidou A, Tzioufas AG, Voulgarelis M (2006) Suspects in the tale of lupus-associated thrombocytopenia. Clin Exp Immunol 145:71–80

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Dean GS, Price JT, Crawley E, Isenberg DA (2000) Cytokines and SLE. Ann Rheum Dis 59:243–251

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Sturfelt G, Bengtsson A, Klint C, Nived O, Sjoholm A, Truedsson L (2000) Novel roles of complement in SLE–hypothesis for a pathogenetic vicious circle. J Rheumatol 27:662

    Google Scholar 

  21. Fugger L, Morling N, Ryder LP, Georgsen J, Jakobsen BK, Svejgaard A, Andersen V, Oxholm P, Karup Pedersen F, Friis J (1989) NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases. Tissue Antigens 34:17–22

    Article  CAS  PubMed  Google Scholar 

  22. Rudwaleit M, Tikly M, Khamashta M, Gibson K, Klinke J, Hughes G, Wordsworth P (1996) Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol 23:1725–1728

    CAS  PubMed  Google Scholar 

  23. Zuniga J, Vargas-Alarcón G, Hernández-Pacheco G, Portal-Cel-hay C, Yamamoto-Furusho JK, Granados J (2001) Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun 2:363–366

    Article  CAS  PubMed  Google Scholar 

  24. D’Alfonso S, Colombo G, Della Bella S, Scorza R, Momigliano Richiardi P (1996) Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population. Tissue Antigens 47:551–555

    Article  PubMed  Google Scholar 

  25. Hirankarn N, Avihingsanon Y, Wongpiyabovorn J (2007) Genetic susceptibility to SLE is associated with TNF-alpha gene polymorphism -863, but not −308 and -238, in Thai population. Int J Immunogenet 34(6):425–430

    Article  CAS  PubMed  Google Scholar 

  26. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, DuV GW (1993) An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 177:557–560

    Article  CAS  PubMed  Google Scholar 

  27. Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GM, Verduyn W, Westendorp RG, de Vries RR, Breedveld FC, Verweij CL, Huizinga TW (2000) TNF−308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 43:129–134

    Article  CAS  PubMed  Google Scholar 

  28. Lin YJ, Chen RH, Wan L, Sheu JC, Huang CM, Lin CW, Chen SY, Lai CH, Lan YC, Hsueh KC, Tsai CH, Lin TH, Huang YM, Chao K, Chen DY, Tsai FJ (2009) Association of TNF-alpha gene polymorphisms with systemic lupus erythematosus in Taiwanese patients. Lupus 18(11):974–979

    Article  PubMed  Google Scholar 

  29. Fonseca JE, Cavaleiro J, Teles J, Sousa E, Andreozzi VL, Antunes M, Amaral-Turkman MA, Canhão H, Mourão AF, Lopes J, Caetano-Lopes J, Weinmann P, Sobral M, Nero P, Saavedra MJ, Malcata A, Cruz M, Melo R, Braña A, Miranda L, Patto JV, Barcelos A, da Silva JC, Santos LM, Figueiredo G, Rodrigues M, Jesus H, Quintal A, Carvalho T, da Silva JA, Branco J, Queiroz MV (2007) Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoter. Arthritis Res Ther 9:37

    Article  CAS  Google Scholar 

  30. Mourao AF, Caetano-Lopes J, Costa P, Canhao H, Santos MJ, Pinto P, Brito I, Nicola P, Cavaleiro J, Teles J, Sousa A, Gomes JM, Branco J, da Costa JT, Pedro JG, de Queiroz MV, Fonseca JE (2009) Tumor necrosis factor-alpha −308 genotypes influence inflammatory activity and TNF-alpha serum concentrations in children with juvenile idiopathic arthritis. J Rheumatol 36:837–842

    Google Scholar 

  31. Sousa E, Caetano-Lopes J, Pinto P, Pimentel F, Teles J, Canho H Rodrigues A, Resende C, Mourão AF, Ribeiro C,  Pinto T, Rosa C, Da Silva J, Branco J, Ventura F, Queiroz M, Fonseca J (2009) Ankylosing spondylitis susceptibility and severity contribution of TNF gene promoter polymorphisms at positions -238 and -308. Ann N Y Acad 1173:581–588

    Google Scholar 

  32. Erik JM, Pilar B, Jaap F, Arjan PM, Agnes ME, Pierre M, Hubert M, Hans S, van Piet Riel LCM, Barbara F, Marieke JH (2012) Meta-analysis identified the TNFA−308 G>A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritis. Curr Rheumatol Rep 4(4):359–367

    Google Scholar 

  33. Abraham LJ, Kroeger KM (1999) Impact of the –308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 66(4):562–566

    CAS  PubMed  Google Scholar 

  34. Fugger L, Morling N, Ryder LP, Georgsen J, Jakobsen BK, Svejgaard A, Andersen V, Oxholm P, Karup Pedersen F, Friis J (1989) NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases. Tissue Antigens 34:17–22

    Article  CAS  PubMed  Google Scholar 

  35. Panoulas VF, Nikas SN, Smith JP, Douglas KM, Nightingale P, Milionis HJ, Treharne GJ, Toms TE, Kita MD, Kitas GD (2008) Lymphotoxin 252 A>G polymorphism is common and associates with myocardial infarction in patients with rheumatoid arthritis. Ann Rheum Dis 67:1550–1556

    Article  CAS  PubMed  Google Scholar 

  36. Messer G, Spengler U, Jung MC, Honold G, Blömer K, Pape GR, Riethmüller G, Weiss EH (1991) Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production. J Exp Med 173(1):209–219

    Article  CAS  PubMed  Google Scholar 

  37. Calmon-Hamaty F, Combe B, Hahne M, Morel J (2011) Lymphotoxin α stimulates proliferation and pro-inflammatory cytokine secretion of rheumatoid arthritis synovial fibroblasts. Cytokine 53(2):207–214

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare no conflicts of interest with respect to the authorship and/or publication of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fatma Mohamed Taha.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahmed, H.H., Taha, F.M., Darweesh, H.ES. et al. Association between TNF promoter −308 G>A and LTA 252 A>G polymorphisms and systemic lupus erythematosus. Mol Biol Rep 41, 2029–2036 (2014). https://doi.org/10.1007/s11033-014-3051-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-014-3051-7

Keywords

Navigation